Almost 2 years we been living in the shadow/fear of a virus. When we thought we almost conquer it. It transformed like Megaton into another mutation/variant.
During this period,  many seasoned traders felt that their portfolio was infected by Covid & suffered a setback.
While new traders felt that their portfolio is on "vaccinated" journey 🚀🌛. However,  the journey to the moon may ended in explosion for some newbies. When they realised it, they're on 🔥 🔥 🔥  in flames.
Forging ahead, as retail traders, we may never see the far months ahead. Maybe the Mega Storm is lurking not far in the future. But what we can do, is to give our offering 🍗🍗 (investment) to the Market God. Some sacrifice👰‍♂️(losses) will be made in order to please the Market God to lead us to prosperity 💰💰 (uptrend)
Huat Ah 2022 发发发 🚀🚀🌛🌛
$Tesla(TSLA.US)$
$Apple(AAPL.US)$
$SNDL Inc(SNDL.US)$
$AMC Entertainment(AMC.US)$
$Palantir(PLTR.US)$
$Genting Sing(G13.SG)$
$Lucid Group(LCID.US)$
$SIA(C6L.SG)$
$Futu Holdings Ltd(FUTU.US)$
$UP Fintech(TIGR.US)$
$Camber Energy(CEI.US)$
$XPeng(XPEV.US)$
$NIO Inc(NIO.US)$
$Alibaba(BABA.US)$
$Pfizer(PFE.US)$
$Grab Holdings(GRAB.US)$
$BlackBerry(BB.US)$
$Moderna(MRNA.US)$
$Singtel(Z74.SG)$

Moderna Booster Protect from Omicron!
like the comment for the green day ahead✌🏻
https://www.cnbc.com/amp/2021/12/20/moderna-says-booster-of-its-covid-vaccine-appears-to-protect-against-omicron.html
$Portillo’s Inc.(PTLO.US)$  $Tesla(TSLA.US)$  $Lucid Group(LCID.US)$  $Gores Guggenheim(GGPI.US)$  $Grab Holdings(GRAB.US)$  $Apple(AAPL.US)$  $Meta Platforms(FB.US)$  $Microsoft(MSFT.US)$  $Nasdaq Composite Index(.IXIC.US)$  $Advanced Micro Devices(AMD.US)$  $Moderna(MRNA.US)$

$Moderna(MRNA.US)$ announced Monday that a third dose of its mRNA vaccine against Covid-19 appears to provide significant protection against the omicron variant.
The company said that its authorized booster can “boost neutralizing antibody levels 37-fold higher than pre-boost levels,” which it described as reassuring.
However, it also said that a double dose of the booster shot — 100 micrograms, rather than the approved 50 micrograms — was significantly more effective. A 100 microgram booster dose increased neutralizing antibody levels “approximately 83-fold,” according to preliminary data, it said in a release.
The 100 microgram dose of its booster shot was “generally safe and well tolerated,” Moderna said, though “there was a trend toward slightly more frequent adverse reactions following the 100 [microgram] booster dose relative to the authorized 50 [microgram] dose.”
Without a booster, the company’s vaccine, called mRNA-1273, was been found to be far less effective against the fast-spreading omicron variant, generating low neutralizing antibodies.
The data have not yet been peer reviewed.

$Moderna(MRNA.US)$ Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant in laboratory testing and that the current version of the vaccine would continue to be Moderna’s "first line of defense against Omicron."
The vaccine maker said the decision to focus on the current vaccine, mRNA-1273, was driven in part by how quickly the recently discovered variant is spreading. The company said it still plans to develop a vaccine to protect against Omicron and hopes to advance into clinical trials early next year.
Moderna's shares were up about 6.5% at $314.42 in premarket trade.
"What we have available right now is 1273," Dr. Paul Burton, Moderna's Chief Medical Officer, said in an interview. "It's highly effective, and it's extremely safe. I think it will protect people through the coming holiday period and through these winter months, when we're going to see the most severe pressure of Omicron."
The company said a two-dose course of its vaccine generated low neutralizing antibodies against the Omicron variant, but a 50 microgram booster dose increased neutralizing antibodies against the variant 37 fold. A higher, 100 microgram booster dose of the same vaccine drove antibody levels even higher - more than 80 times pre-boost levels.

$Advanced Micro Devices(AMD.US)$ - as expected lot of buyers coming in on this one. Calls above $148. Looking for $150 plus
$Zscaler(ZS.US)$  - Zscaler Added To Nasdaq-100 Index Effective Monday, Dec. 20, 2021. Calls above $315
$UnitedHealth(UNH.US)$ - stock hitting all time highs. Looking very strong. Calls above $497.

$Meta Platforms(FB.US)$ - Stock Near 50 EMA line. Looking to add calls above $335
$Zscaler(ZS.US)$ - Zscaler Added To Nasdaq-100 Index Effective Monday, Dec. 20, 2021. On watch for pre joining movementum.
$Alibaba(BABA.US)$ - Alibaba has registered a new company named Yuanjing Shengsheng in Beijing to test the gaming potential of the metaverse, it was reported on Tuesday, citing the South China Morning Post.
$Eli Lilly and Co(LLY.US)$ - Eli Lilly Says Mirikizumab Demonstrates Superiority Over Placebo In Phase 3 Maintenance Study In Ulcerative Colitis, Supporting Regulatory Submissions In 2022.
$NVIDIA(NVDA.US)$ - stock is holding a $280 support level. On watch for another move to $300 plus.

Market Sentiment
What a year 2021 has been. The tiny SARS-CoV2 virus is still messing up with our daily lives. Just when things were starting to normalise, a newly discovered variant Omicron threw a curve ball causing some countries to halt or even reverse decisions to re-open borders.
As end of 2021 approaches, the market mood has dampened down quite a bit. The market breadth is not looking rosy, more stocks are below MA200 than above. The impeding QE tapping and interest rate hikes in respond to rising inflation by US Fed are weighing down market sentiment too.
In the trading landscape, a strong bull was dominating the market in the first three quarters of 2021. Major indices were breaking all time high, even cryptocurrency was making waves (pun intended, super volatile moves for $Bitcoin(BTC.CC)$ Bitcoin).
Covid-19 Theme
Feb 2021 saw the start of the largest vaccination drive than mankind has ever seen. Previous vaccination programmes were generally rolled out over years or decades. But the advancement of biotechnology has allowed us to access COVID-19 vaccine in unprecedented speed.
Moderna $Moderna(MRNA.US)$, BioNtech $BioNTech(BNTX.US)$, Pfizer $Pfizer(PFE.US)$, Johnson & Johnson $Johnson & Johnson(JNJ.US)$, Novavax $Novavax(NVAX.US)$, Astra Zeneca $ASTRAZENECA PLC(AZNCF.US)$ just to name a few obvious ones, roared to all time high. Did you catch the train? I took a small profitable swing trade with Pfizer. Nothing to boast about, purely practicing my trading skills based on breakout trend.
Good Trade Execution: Timing to Exit Trade Perfectly
One memorable trade in 2021 for me was with Open $Opendoor Technologies(OPEN.US)$. Been learning to read chart with Wyckroff method so it was great to be able to time my exit of Open perfectly before the price crashed.
This was the chart analysis and trading plan for my position on 22 Sept.
I tried to protect profit my trailing my stop loss. As the market unfolds, the news about Zillow $Zillow-C(Z.US)$ shook Open badly. Based on my analysis of the price action and volume, I moved my stop loss lower to wait for a rebound in order to exit the trade with profit. This manoeuvre helped me exited with 21% profit in around 6 weeks.
The biggest take away from this trade? Applying Wyckroff analysis of price action to manage my trade successfully despite drastic bad news.
Bad Trading Execution: Importance of Stop Loss
Think any trader would be able to tell you anecdotes of how stop loss either dented or saved their capital. Sharing a lesson of moving stop loss. After Nvidia $NVIDIA(NVDA.US)$ share split, I decided to initiate a long entry on 26 July at $193. The plan was to take advantage of the break out pattern fueled by the strong demand on chips. Given Nvidia is such a darling of both short and long term investors, the initial trading plan was to hold on to long position for as long as possible.
The price moved uptrend until hitting resistance at $231. Things were looking rosy and I was feeling very pleased with myself. Then came a minor correction to the magnitude of 15% from $231 to $195. It was nerve wrecking then. Everyday I would be checking on the paper loss and debating if I should close my position to protect whatever profit I had. I decided to move stop loss to $198. Luck was not on my side and the price touched $197 and reversed.
It was such a painful lesson. On hide sight, there was no reason for me to panic. No sudden increase in volume to suggest investors are dumping Nvidia. I should have just stay calm and allow the correction to unfold. I lost in this trade because I gave in to my panic and not sticking to trading plan.
Outlook for 2022
Current market condition seems to be rather uncertain. Nasdaq $Nasdaq Composite Index(.IXIC.US)$, S&P $S&P 500 Index(.SPX.US)$ and Dow $Dow Jones Industrial Average(.DJI.US)$ all suffering corrections. There are many factors affecting the 2022 outlook. US Federal Bank meeting in mid Dec, Omicron concerns and its closely related national border policies will likely impact market condition. I would be very cautious in trading until things get more clarity. Stay away from stocks that corrected by 30% (e.g. U $Unity Software(U.US)$, Baba $Alibaba(BABA.US)$, Palantir $Palantir(PLTR.US)$), and monitor defensive counters such as PG $Procter & Gamble(PG.US)$, TSN $Tyson Foods(TSN.US)$.
Last Words
To me, trading is like an art of understanding the market forces. Is the bull or bear in charge currently? Do I expect a correction or continuation of trend?
The biggest lesson in 2021 from my trades is learning to execute trading plans with confidence. Trust my analysis of the market and not getting emotional.
For 2022, I certainly hope to be a consistently profitable trader by improving my chart analysing skills and trade execution.
Sharing this and hope for a better 2022 to all!

2021 is a year of volatility. It has witnessed the rise of meme stocks, starting with $GameStop(GME.US)$ and WallStreeBets early in January and up to the moon $AMC Entertainment(AMC.US)$ in June. After the 2020 pandemic, S&P 500 rallied 100% within 354 trading days*. In times of chip shortage, investors are also watching the tech stocks closely. Not to mention dramas like what caused by Elon Musk and Donald Trump on $Tesla(TSLA.US)$ and $Digital World Acquisition Corp(DWAC.US)$ . What a year!
*Source: CNBC Maekets News
Review Your 2021 to Win Free Stocks
As 2021 comes to an end, moomoo invites you to write your own review of 2021 trading journey, reflecting on the year that was and looking ahead to 2022. Join the topic discussion "2021 in Review: My Investing Journey Forges Ahead" and get rewards now! 
Event Duration: Now to December 31st, 11:59pm ET
Rewards*:
1. Top 40 posts will get FREE stock with a price range from $5 to $30.
2. 9 Growing Stars of the Year* will get FREE stock with a price range from $20 to $50.
3. All relevant posts with no less than 20 words will be rewarded with 88 points.
*Participants before December 22nd stand a chance to become Growing Stars of the Year, which is a title given by moomoo community to reward your effort made in 2021. A badge will be given to Growing Stars on the profile page to acknowledge your progress and achievement. The Growing Star will be rewarded with one random moomoo merchandise and one free stock with a price range from $20 to $50. 
*Note: One can only get one out of the three rewards mentioned above.
The above rewards will be issued in 15 working days after the event ends.
Selection criteria:
(applied to both Top 40 posts and Growing Stars)
1. Content quality: a comprehensive review of 2021.
2. Good typesetting with order histories, stock's trend or other helpful charts.
3. User interaction with the post.
4. Relevant tickers added.
How to join?
Click here and join the discussion under the topic, and you stand a chance to win the free stocks! Easy peasy!
Don't know what to write? Ask yourself the following three questions!
ONE: How did your trades perform?
As we approach the end of 2021, it's time to look back on whether you make money over 2021! Where did you put your money in? Did your stocks bring you good returns? What are your highlights this year in trading? 
Reviewing your trading performance is a way to acknowledge successes and drawbacks to improve your trading skills. Let's check out what moomoo features you could adopt to assist the writing of your reviews here.
TWO: What have you learned from trading? 
Perhaps you made a profit, learned a new trading skill, developed good trading psychology, broke bad habits, and gained more confidence.
Even if 2021 might not be the best year in trading, time must have rewarded you with something greater than money, and that is AWESOME! What lesson did you learn, and what progress did you make? Write down the trading knowledge you've learned over the year now!
THREE: What cool thins have you done? 
2020 might be the worst year for many people as COVID-19 took away so many innocent lives. Is 2021 getting better with you? What are your stories this year? Did you meet any good fellows during your trading journey? 
We are all ears for your remarkable stories! Please remember, mooers will always be by your side no matter what happens.
Final Words: 2022 Will Be Everything You Want It To Be
Moving forward, it isn't just about learning from what didn't' work in 2021, but also about learning, acknowledging, and genuinely appreciating what did work in the past. You should allow yourself to be happy and truly soak it all in if you want to thrive.
Happy (almost) 2022, and remember, this year—it's going to be what you want it to be.
Join discussion and get rewards now! Click here: "2021 in Review: My Investing Journey Forges Ahead"
*Write Your Original Ideas: Plagiarism or cheating is not acceptable in any activities on moomoo. Please "Report" the suspicious posts if you find any. Once confirmed, the user committed shall be disqualified from the activities.
moomoo annual ceremony is happening right now! Check it out here:  2021 in Review: Grow Together to the Moon!

$Zscaler(ZS.US)$ Zscaler is a cloud-based information security platform delivered through more than 100 global data centers.
Zscaler recently posted it’s earnings report for Q1 2022. They posted earnings of 14 cents a share, higher than analyst estimates of 12 cents. Their billings grew 71% to $247.7 million from $144.7 million in the previous year, beating estimates of $203.6 million.
How do you guys think this company will perform in 2022?